Mohammad Hirmand - Net Worth and Insider Trading

Mohammad Hirmand Net Worth

The estimated net worth of Mohammad Hirmand is at least $6 Million dollars as of 2024-05-02. Mohammad Hirmand is the Interim Chief Medical Officer of Medivation Inc and owns about 39,342 shares of Medivation Inc (MDVN) stock worth over $3 Million. Mohammad Hirmand is also the EVP & Chief Medical Officer of Turning Point Therapeutics Inc and owns about 40,821 shares of Turning Point Therapeutics Inc (TPTX) stock worth over $3 Million. Details can be seen in Mohammad Hirmand's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mohammad Hirmand has not made any transactions after 2022-02-09 and currently still holds the listed stock(s).

Transaction Summary of Mohammad Hirmand

To

Mohammad Hirmand Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mohammad Hirmand owns 3 companies in total, including Turning Point Therapeutics Inc (TPTX) , Medivation Inc (MDVN) , and Aadi Bioscience Inc (AADI) .

Click here to see the complete history of Mohammad Hirmand’s form 4 insider trades.

Insider Ownership Summary of Mohammad Hirmand

Ticker Comapny Transaction Date Type of Owner
TPTX Turning Point Therapeutics Inc 2022-02-09 EVP and Chief Medical Officer
MDVN Medivation Inc 2016-09-28 Interim Chief Medical Officer
AADI Aadi Bioscience Inc 2023-03-27 director

Mohammad Hirmand Latest Holdings Summary

Mohammad Hirmand currently owns a total of 2 stocks. Among these stocks, Mohammad Hirmand owns 39,342 shares of Medivation Inc (MDVN) as of March 4, 2016, with a value of $3 Million and a weighting of 50.8%. Mohammad Hirmand also owns 40,821 shares of Turning Point Therapeutics Inc (TPTX) as of February 9, 2022, with a value of $3 Million and a weighting of 49.2%.

Latest Holdings of Mohammad Hirmand

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MDVN Medivation Inc 2016-03-04 39,342 81.44 3,204,012
TPTX Turning Point Therapeutics Inc 2022-02-09 40,821 76.01 3,102,804

Holding Weightings of Mohammad Hirmand


Mohammad Hirmand Form 4 Trading Tracker

According to the SEC Form 4 filings, Mohammad Hirmand has made a total of 0 transactions in Medivation Inc (MDVN) over the past 5 years. The most-recent trade in Medivation Inc is the sale of 1,525 shares on March 4, 2016, which brought Mohammad Hirmand around $62,678.

According to the SEC Form 4 filings, Mohammad Hirmand has made a total of 2 transactions in Turning Point Therapeutics Inc (TPTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Turning Point Therapeutics Inc is the sale of 669 shares on February 9, 2022, which brought Mohammad Hirmand around $24,285.

Insider Trading History of Mohammad Hirmand

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mohammad Hirmand Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mohammad Hirmand Ownership Network

Ownership Network List of Mohammad Hirmand

No Data

Ownership Network Relation of Mohammad Hirmand


Mohammad Hirmand Owned Company Details

What does Turning Point Therapeutics Inc do?

Who are the key executives at Turning Point Therapeutics Inc?

Mohammad Hirmand is the EVP and Chief Medical Officer of Turning Point Therapeutics Inc. Other key executives at Turning Point Therapeutics Inc include EVP & Chief Financial Officer Paolo Tombesi , SVP & Chief Commercial Officer Steve M Sabus , and SVP & General Counsel Brian Sun .

Turning Point Therapeutics Inc (TPTX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Turning Point Therapeutics Inc (TPTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Turning Point Therapeutics Inc (TPTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Turning Point Therapeutics Inc (TPTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Turning Point Therapeutics Inc Insider Transactions

No Available Data

Mohammad Hirmand Mailing Address

Above is the net worth, insider trading, and ownership report for Mohammad Hirmand. You might contact Mohammad Hirmand via mailing address: C/o Medivation, Inc., 525 Market St., 36th Floor, San Francisco Ca 94105.

Discussions on Mohammad Hirmand

No discussions yet.